Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | TDO2 | P48775 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8363742 | 0.81 | SMN1; SMN2 (0.31) | SMN1; SMN2 | |
| SCHEMBL11479185 | 0.80 | TSHR (0.39) | TSHRCYP2C19MEN1KMT2AIDO1 | |
| SCHEMBL21371635 | 0.77 | TSHR (0.38) | TSHRCYP2C19MEN1KMT2AIDO1 | |
| SCHEMBL13948016 | 0.77 | TSHR (0.31) | TSHRCYP2C19 | |
| SCHEMBL11353453 | 0.77 | CNR1 (0.43) | SMN1; SMN2 | |
| SCHEMBL21371646 | 0.76 | POLB (0.40) | TSHRCYP2C19MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL11479387 | 0.76 | TSHR (0.33) | TSHRCYP2C19MEN1KMT2A | |
| SCHEMBL3243759 | 0.75 | LMNA (0.36) | KMT2ASMN1; SMN2 | |
| SCHEMBL11593495 | 0.75 | LMNA (0.36) | KMT2ASMN1; SMN2L3MBTL1 | |
| SCHEMBL11153550 | 0.75 | CNR1 (0.48) | CYP2C19SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090054467-A1 | Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases | BETSCHART CLAUDIA | 2009-02-26 | — | — | US | disclosed |
| US-7452886-B2 | Pyrrolo pyrimidines as agents for the inhibition of cystein proteases | NOVARTIS AG (CH) | 2008-11-18 | — | — | US | disclosed |
| US-7452886-B2 | Pyrrolo pyrimidines as agents for the inhibition of cystein proteases | NOVARTIS AG (CH) | 2008-11-18 | — | — | US | disclosed |
| US-4371644-A | Piperidine derivatives and their use as polymer stabilizers | SANKYO COMPANY LTD. (JP) | 1983-02-01 | — | — | US | disclosed |
| EP-0007468-B1 | COMPOSITIONS PHOTODURCISSABLES | CIBA-GEIGY AG (CH) | 1982-04-07 | — | — | EP | disclosed |
| US-4284485-A | STABILIZED WITH A POLYALKYLPIPERIDINE DERIVATIVE | CIBA-GEIGY CORPORATION (US) | 1981-08-18 | — | — | US | disclosed |
| US-4279720-A | PHENYLGLYOXYLATE PHOTOINITIATOR WITH POLYALKYLPIPERIDINE STABILIZER | CIBA-GEIGY CORPORATION (US) | 1981-07-21 | — | — | US | disclosed |
| EP-0007059-B1 | PHOTOCURABLE COMPOSITIONS | CIBA-GEIGY AG (CH) | 1981-04-15 | — | — | EP | disclosed |
| EP-0007059-A1 | Photocurable compositions | CIBA-GEIGY AG (CH) | 1980-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054467-A1 | Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases | CTSK, CTSS, CTSZ | TSHR 4339/4885CYP2C19 1412/4885MEN1 4225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.